BPG is committed to discovery and dissemination of knowledge
Review
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. May 16, 2015; 7(5): 481-495
Published online May 16, 2015. doi: 10.4253/wjge.v7.i5.481
Recent advancement of therapeutic endoscopy in the esophageal benign diseases
Robert Bechara, Haruhiro Inoue
Robert Bechara, Haruhiro Inoue, Digestive Diseases Center, Showa University Koto-Toyosu Hospital, Koto-ku, Tokyo 135-0061, Japan
Author contributions: Bechara R and Inoue H both contributed to the writing of this paper.
Conflict-of-interest: None.
Correspondence to: Robert Bechara, HonBSc, MD, FRCPC, Digestive Diseases Center, Showa University Koto-Toyosu Hospital, 5-1-38 Toyosu, Koto-ku, Tokyo 135-0061, Japan. bechara.robert@gmail.com
Telephone: +81-3-62046064 Fax: +81-3-62046998
Received: October 28, 2014
Peer-review started: November 2, 2014
First decision: December 26, 2014
Revised: January 13, 2015
Accepted: February 4, 2015
Article in press: February 9, 2015
Published online: May 16, 2015
Processing time: 201 Days and 15.5 Hours
Core Tip

Core tip: Antireflux mucosectomy is an endoscopic antireflux procedure showing promising results in patients with refractory gastroesophageal reflux. Over the scope clips and esophageal stents permit safe endoscopic closure of esophagogastric defects, decreasing the requirement for surgical intervention. Per-oral endoscopic myotomy allows the precise performance of endoscopic myotomy for the treatment of spastic esophageal motility disorders with the efficacy of a surgical myotomy without the associated surgical morbidity. Per-oral endoscopic tumor resection enables en bloc endoscopic removal of subepithelial tumors (SETs) and is both a diagnostic and therapeutic intervention for esophageal SETs. These techniques will expand the boundaries of therapeutic endoscopy, decrease the need for surgical intervention, and improve patient outcomes.